Therapeutic targets in age-related macular disease
- 1 September 2010
- journal article
- review article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 120 (9), 3033-3041
- https://doi.org/10.1172/jci42437
Abstract
Age-related macular disease (AMD) accounts for more than 50% of blind registration in Western society. Patients with AMD are classified as having early disease, in which visual function is well preserved, or late disease, in which central vision is lost. Until recently, there was no therapy available by which the course of the disorder could be modified. Now, the most common form of late-stage AMD — choroidal neovascularization — responds to treatment with anti-VEGF therapies; although visual loss is modified in a portion of these cases, no therapeutic approach exists that alters the evolution from early to late disease. However, as discussed in this Review, research over the last few years has demonstrated several features of AMD that are likely to be amenable to treatment. Potential targets for treatment are described, and possible therapeutic approaches are discussed.Keywords
This publication has 117 references indexed in Scilit:
- The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visitedProgress in Retinal and Eye Research, 2010
- Soluble and Mature Amyloid Fibrils in Drusen DepositsInvestigative Ophthalmology & Visual Science, 2010
- An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillarisProceedings of the National Academy of Sciences of the United States of America, 2009
- Multilocus analysis of age-related macular degenerationEuropean Journal of Human Genetics, 2009
- Complement Activation by Bisretinoid Constituents of RPE LipofuscinInvestigative Ophthalmology & Visual Science, 2009
- Mitochondrial function and redox control in the aging eye: Role of MsrA and other repair systems in cataract and macular degenerationsExperimental Eye Research, 2009
- VEGF modulation of retinal pigment epithelium resistanceExperimental Eye Research, 2007
- Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunctionProceedings of the National Academy of Sciences of the United States of America, 2007
- The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- Complement Factor H Polymorphism in Age-Related Macular DegenerationScience, 2005